Injectable Drug Recalls Raise Particulate-Contamination Concerns

Par Health Sciences recalled two Brevital lots for cellulose particulate that could cause pulmonary or other vascular blockages. A newly read report describes a separate recall of 22 argatroban lots over particles and potential serious vascular or tissue harms; confirm official lot details and instructions, and note that no associated argatroban adverse events were reported in that article.